Alberta Investment Management Corp Takes $2.57 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Alberta Investment Management Corp bought a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) during the 4th quarter, HoldingsChannel reports. The fund bought 135,600 shares of the medical instruments supplier’s stock, valued at approximately $2,574,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nordea Investment Management AB increased its position in shares of DENTSPLY SIRONA by 245.0% in the fourth quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier’s stock valued at $4,754,000 after acquiring an additional 178,639 shares during the period. JPMorgan Chase & Co. grew its stake in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the last quarter. Barclays PLC grew its stake in shares of DENTSPLY SIRONA by 21.8% in the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock worth $8,301,000 after purchasing an additional 54,920 shares during the last quarter. Canvas Wealth Advisors LLC increased its holdings in DENTSPLY SIRONA by 126.5% during the 4th quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock valued at $6,245,000 after purchasing an additional 182,234 shares during the period. Finally, Quantinno Capital Management LP raised its position in DENTSPLY SIRONA by 276.5% during the 3rd quarter. Quantinno Capital Management LP now owns 116,808 shares of the medical instruments supplier’s stock valued at $3,161,000 after purchasing an additional 85,787 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. Morgan Stanley cut their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Leerink Partnrs cut shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Evercore ISI reaffirmed an “in-line” rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $25.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, February 11th. Ten investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $25.85.

Check Out Our Latest Report on XRAY

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $18.95 on Friday. The company has a 50 day simple moving average of $18.94 and a two-hundred day simple moving average of $21.75. DENTSPLY SIRONA Inc. has a fifty-two week low of $17.21 and a fifty-two week high of $34.91. The company has a market capitalization of $3.77 billion, a price-to-earnings ratio of -9.15, a P/E/G ratio of 1.79 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.38%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA’s payout ratio is -30.92%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Recommended Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.